Navigation Links
2Blades Announces Completion of a Non-exclusive License With Epicrop Technologies Inc. For Access to the TAL Code Technology
Date:11/5/2018

2Blades has completed a non-exclusive license agreement with Epicrop Technologies Inc., for access to 2Blades’ Transcription Activator Like (TAL) effector code technology for applications in advancing research in epigenetic technology.

2Blades holds exclusive rights for commercial uses of the technology in plants. Since its discovery in 2009, the efficacy of TAL effector-based DNA targeting has been established rapidly in a wide range of plant and non-plant systems. The use of the TAL code technology in plants has enhanced the efficiency and precision of the crop improvement process.

“We’re pleased to complete a license with Epicrop for access to the TAL code technology. It provides tools that can advance their efforts to develop epigenetic breeding methods to improve crop yield and stress tolerance," said 2Blades President Diana Horvath. 

“We are pleased to be able to utilize this technology in our research to improve yields and stress tolerance in crops,” said Michael Fromm, CEO of Epicrop. “Research with this technology will help us to more efficiently optimize our conventional breeding methods for improving epigenetics in crops. Epigenetics is a form of biological information that has always been present in plants, and can be improved by plant breeding as we learn what features are most beneficial for higher stress tolerance and yields in the farmer’s field. It may seem surprising to those more familiar with gene editing and other methods, that our epigenetic breeding methods produce plants that do not contain any changes to their genome sequence or introduce any foreign DNA sequences. Epigenetic improvements are analogous to a ‘software update’ that helps the plant’s natural genetics perform better without changing the ‘hardware’ of the genetic sequences.”

The financial terms of the agreement were not disclosed.

The TAL Code technology was discovered by Ulla Bonas, Jens Boch, Thomas Lahaye, and Sebastian Schornack at Martin-Luther University in Halle, Germany and was named 2011 Method of the Year by the journal Nature Methods (9:1 doi:10.1038/nmeth.1852).  In 2012, 2Blades was recognized for the TAL Code technology by the Agrow Awards in the category of Best Novel Agricultural Biotechnology.

Read the full story at https://www.prweb.com/releases/2018/11/prweb15886440.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. MCC Announces: Dr. Jean Mulinde, CDER, FDA Confirmed Speaker at Clinical Trial Risk and Performance Management Summit, Nov. 14-15, 2018, Princeton, NJ
2. Myoscience Announces the Completion of Enrollment in the Campbell Clinic Study
3. Molecular Devices Announces Brand Identity for Its Newly-Formed Biologics Business Unit
4. AMIA Announces 2018 Signature Award and Leadership Award Recipients
5. Voxx Analytics Announces Release of Voxx.Gateway for Medical Device and Early-Stage Life Science Companies
6. GlycoMark®, Inc. Announces Partnership with Premier Medical Laboratory Services to Expand Diabetes Test Menu
7. LabRoots Announces Winner for the Second Annual Summer Textbook Scholarship
8. NanoScientific Symposium on SPM at SUNY Polytechnic Announces Registration for Live Stream of Event Sept. 19, 2018
9. Nanovis Announces Successful Completion of $5.5 Million Investment Round To Fund Technology-Driven Growth
10. The Freedom from Cancer Startup Challenge Announces Companies Advancing 100+ Cancer Inventions
11. SkylineDx Announces Prognostic Tool to be Used as Part of Major New Myeloma Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2018)... ... December 19, 2018 , ... ... its first rate Stem Cell Training Course in Las Vegas. Training includes facial ... regenerative procedures explode in popularity nationwide for aesthetics, having the training from expert, ...
(Date:12/14/2018)... , ... December 14, 2018 , ... ... Canada Inc., have been given the green light to immediately begin a clinical ... (AMD). , The medical devices bureau of Health Canada has granted what is ...
(Date:12/10/2018)... ... December 10, 2018 , ... ... Manufacturing Organization (CDMO) with sites in China and the United States, providing ... fill finish solutions for monoclonal antibody (mAb) and antibody-drug conjugate (ADC) therapeutics, ...
(Date:11/29/2018)... ... November 29, 2018 , ... RAGS, today announced the closing ... Seed Fund, with participation from existing investor and board member Jeremy Andrus, CEO of ... Cotopaxi. The additional funding will enable the company to accelerate its growth and expand ...
Breaking Biology Technology:
(Date:1/7/2019)... ... January 07, 2019 , ... ... supplier of Graph Database technology for Knowledge Graphs solutions, announced that it was ... ‘Trend-Setting’ Product . DBTA’s data and information management recognition list includes newer ...
(Date:12/27/2018)... ... December 27, 2018 , ... AxioMed ... at its new Boston facility, and is now raising growth capital to ramp ... expand market share against inferior ball and socket discs. The capital raise is ...
(Date:12/19/2018)... (PRWEB) , ... December 19, 2018 , ... NDA Partners ... Reviewer and Compliance Officer at the FDA Center for Devices and Radiological Health (CDRH), ... Partners as an Expert Consultant since 2015, and she has more than 25 years ...
Breaking Biology News(10 mins):